View in EDS

Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial.

Saved in:
Bibliographic Details
Title: Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial.
Authors: Azizi, Michel (AUTHOR), Sanghvi, Kintur (AUTHOR), Saxena, Manish (AUTHOR), Gosse, Philippe (AUTHOR), Reilly, John P (AUTHOR), Levy, Terry (AUTHOR), Rump, Lars C (AUTHOR), Persu, Alexandre (AUTHOR), Basile, Jan (AUTHOR), Bloch, Michael J (AUTHOR), Daemen, Joost (AUTHOR), Lobo, Melvin D (AUTHOR), Mahfoud, Felix (AUTHOR), Schmieder, Roland E (AUTHOR), Sharp, Andrew S P (AUTHOR), Weber, Michael A (AUTHOR), Sapoval, Marc (AUTHOR), Fong, Pete (AUTHOR), Pathak, Atul (AUTHOR), Lantelme, Pierre (AUTHOR)
Source: Lancet. 6/26/2021, Vol. 397 Issue 10293, p2476-2486. 11p.
Subjects: Hypertension, Ultrasonic imaging, Systolic blood pressure, Denervation, Blood pressure, Antihypertensive agents, Diuretics, Research, Kidneys, Renal artery, Operative surgery, Calcium antagonists, Research methodology, Drug resistance, Evaluation research, Comparative studies, Randomized controlled trials, Blind experiment, Ambulatory blood pressure monitoring, Angiotensin receptors, Statistical sampling, Innervation
Geographic Terms: Europe
Abstract: Background: Endovascular renal denervation reduces blood pressure in patients with mild-to-moderate hypertension, but its efficacy in patients with true resistant hypertension has not been shown. We aimed to assess the efficacy and safety of endovascular ultrasound renal denervation in patients with hypertension resistant to three or more antihypertensive medications.Methods: In a randomised, international, multicentre, single-blind, sham-controlled trial done at 28 tertiary centres in the USA and 25 in Europe, we included patients aged 18-75 years with office blood pressure of at least 140/90 mm Hg despite three or more antihypertensive medications including a diuretic. Eligible patients were switched to a once daily, fixed-dose, single-pill combination of a calcium channel blocker, an angiotensin receptor blocker, and a thiazide diuretic. After 4 weeks of standardised therapy, patients with daytime ambulatory blood pressure of at least 135/85 mm Hg were randomly assigned (1:1) by computer (stratified by centres) to ultrasound renal denervation or a sham procedure. Patients and outcome assessors were masked to randomisation. Addition of antihypertensive medications was allowed if specified blood pressure thresholds were exceeded. The primary endpoint was the change in daytime ambulatory systolic blood pressure at 2 months in the intention-to-treat population. Safety was also assessed in the intention-to-treat population. This study is registered with ClinicalTrials.gov, NCT02649426.Findings: Between March 11, 2016, and March 13, 2020, 989 participants were enrolled and 136 were randomly assigned to renal denervation (n=69) or a sham procedure (n=67). Full adherence to the combination medications at 2 months among patients with urine samples was similar in both groups (42 [82%] of 51 in the renal denervation group vs 47 [82%] of 57 in the sham procedure group; p=0·99). Renal denervation reduced daytime ambulatory systolic blood pressure more than the sham procedure (-8·0 mm Hg [IQR -16·4 to 0·0] vs -3·0 mm Hg [-10·3 to 1·8]; median between-group difference -4·5 mm Hg [95% CI -8·5 to -0·3]; adjusted p=0·022); the median between-group difference was -5·8 mm Hg (95% CI -9·7 to -1·6; adjusted p=0·0051) among patients with complete ambulatory blood pressure data. There were no differences in safety outcomes between the two groups.Interpretation: Compared with a sham procedure, ultrasound renal denervation reduced blood pressure at 2 months in patients with hypertension resistant to a standardised triple combination pill. If the blood pressure lowering effect and safety of renal denervation are maintained in the long term, renal denervation might be an alternative to the addition of further antihypertensive medications in patients with resistant hypertension.Funding: ReCor Medical. [ABSTRACT FROM AUTHOR]
Copyright of Lancet is the property of Lancet and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
FullText Text:
  Availability: 0
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 151059162
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Azizi%2C+Michel%22">Azizi, Michel</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sanghvi%2C+Kintur%22">Sanghvi, Kintur</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Saxena%2C+Manish%22">Saxena, Manish</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gosse%2C+Philippe%22">Gosse, Philippe</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Reilly%2C+John+P%22">Reilly, John P</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Levy%2C+Terry%22">Levy, Terry</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rump%2C+Lars+C%22">Rump, Lars C</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Persu%2C+Alexandre%22">Persu, Alexandre</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Basile%2C+Jan%22">Basile, Jan</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bloch%2C+Michael+J%22">Bloch, Michael J</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Daemen%2C+Joost%22">Daemen, Joost</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lobo%2C+Melvin+D%22">Lobo, Melvin D</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mahfoud%2C+Felix%22">Mahfoud, Felix</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schmieder%2C+Roland+E%22">Schmieder, Roland E</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sharp%2C+Andrew+S+P%22">Sharp, Andrew S P</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Weber%2C+Michael+A%22">Weber, Michael A</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sapoval%2C+Marc%22">Sapoval, Marc</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fong%2C+Pete%22">Fong, Pete</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pathak%2C+Atul%22">Pathak, Atul</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lantelme%2C+Pierre%22">Lantelme, Pierre</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Lancet%22">Lancet</searchLink>. 6/26/2021, Vol. 397 Issue 10293, p2476-2486. 11p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Hypertension%22">Hypertension</searchLink><br /><searchLink fieldCode="DE" term="%22Ultrasonic+imaging%22">Ultrasonic imaging</searchLink><br /><searchLink fieldCode="DE" term="%22Systolic+blood+pressure%22">Systolic blood pressure</searchLink><br /><searchLink fieldCode="DE" term="%22Denervation%22">Denervation</searchLink><br /><searchLink fieldCode="DE" term="%22Blood+pressure%22">Blood pressure</searchLink><br /><searchLink fieldCode="DE" term="%22Antihypertensive+agents%22">Antihypertensive agents</searchLink><br /><searchLink fieldCode="DE" term="%22Diuretics%22">Diuretics</searchLink><br /><searchLink fieldCode="DE" term="%22Research%22">Research</searchLink><br /><searchLink fieldCode="DE" term="%22Kidneys%22">Kidneys</searchLink><br /><searchLink fieldCode="DE" term="%22Renal+artery%22">Renal artery</searchLink><br /><searchLink fieldCode="DE" term="%22Operative+surgery%22">Operative surgery</searchLink><br /><searchLink fieldCode="DE" term="%22Calcium+antagonists%22">Calcium antagonists</searchLink><br /><searchLink fieldCode="DE" term="%22Research+methodology%22">Research methodology</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+resistance%22">Drug resistance</searchLink><br /><searchLink fieldCode="DE" term="%22Evaluation+research%22">Evaluation research</searchLink><br /><searchLink fieldCode="DE" term="%22Comparative+studies%22">Comparative studies</searchLink><br /><searchLink fieldCode="DE" term="%22Randomized+controlled+trials%22">Randomized controlled trials</searchLink><br /><searchLink fieldCode="DE" term="%22Blind+experiment%22">Blind experiment</searchLink><br /><searchLink fieldCode="DE" term="%22Ambulatory+blood+pressure+monitoring%22">Ambulatory blood pressure monitoring</searchLink><br /><searchLink fieldCode="DE" term="%22Angiotensin+receptors%22">Angiotensin receptors</searchLink><br /><searchLink fieldCode="DE" term="%22Statistical+sampling%22">Statistical sampling</searchLink><br /><searchLink fieldCode="DE" term="%22Innervation%22">Innervation</searchLink>
– Name: SubjectGeographic
  Label: Geographic Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Europe%22">Europe</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: <bold>Background: </bold>Endovascular renal denervation reduces blood pressure in patients with mild-to-moderate hypertension, but its efficacy in patients with true resistant hypertension has not been shown. We aimed to assess the efficacy and safety of endovascular ultrasound renal denervation in patients with hypertension resistant to three or more antihypertensive medications.<bold>Methods: </bold>In a randomised, international, multicentre, single-blind, sham-controlled trial done at 28 tertiary centres in the USA and 25 in Europe, we included patients aged 18-75 years with office blood pressure of at least 140/90 mm Hg despite three or more antihypertensive medications including a diuretic. Eligible patients were switched to a once daily, fixed-dose, single-pill combination of a calcium channel blocker, an angiotensin receptor blocker, and a thiazide diuretic. After 4 weeks of standardised therapy, patients with daytime ambulatory blood pressure of at least 135/85 mm Hg were randomly assigned (1:1) by computer (stratified by centres) to ultrasound renal denervation or a sham procedure. Patients and outcome assessors were masked to randomisation. Addition of antihypertensive medications was allowed if specified blood pressure thresholds were exceeded. The primary endpoint was the change in daytime ambulatory systolic blood pressure at 2 months in the intention-to-treat population. Safety was also assessed in the intention-to-treat population. This study is registered with ClinicalTrials.gov, NCT02649426.<bold>Findings: </bold>Between March 11, 2016, and March 13, 2020, 989 participants were enrolled and 136 were randomly assigned to renal denervation (n=69) or a sham procedure (n=67). Full adherence to the combination medications at 2 months among patients with urine samples was similar in both groups (42 [82%] of 51 in the renal denervation group vs 47 [82%] of 57 in the sham procedure group; p=0·99). Renal denervation reduced daytime ambulatory systolic blood pressure more than the sham procedure (-8·0 mm Hg [IQR -16·4 to 0·0] vs -3·0 mm Hg [-10·3 to 1·8]; median between-group difference -4·5 mm Hg [95% CI -8·5 to -0·3]; adjusted p=0·022); the median between-group difference was -5·8 mm Hg (95% CI -9·7 to -1·6; adjusted p=0·0051) among patients with complete ambulatory blood pressure data. There were no differences in safety outcomes between the two groups.<bold>Interpretation: </bold>Compared with a sham procedure, ultrasound renal denervation reduced blood pressure at 2 months in patients with hypertension resistant to a standardised triple combination pill. If the blood pressure lowering effect and safety of renal denervation are maintained in the long term, renal denervation might be an alternative to the addition of further antihypertensive medications in patients with resistant hypertension.<bold>Funding: </bold>ReCor Medical. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Lancet is the property of Lancet and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=151059162
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S0140-6736(21)00788-1
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 11
        StartPage: 2476
    Subjects:
      – SubjectFull: Hypertension
        Type: general
      – SubjectFull: Ultrasonic imaging
        Type: general
      – SubjectFull: Systolic blood pressure
        Type: general
      – SubjectFull: Denervation
        Type: general
      – SubjectFull: Blood pressure
        Type: general
      – SubjectFull: Antihypertensive agents
        Type: general
      – SubjectFull: Diuretics
        Type: general
      – SubjectFull: Research
        Type: general
      – SubjectFull: Kidneys
        Type: general
      – SubjectFull: Renal artery
        Type: general
      – SubjectFull: Operative surgery
        Type: general
      – SubjectFull: Calcium antagonists
        Type: general
      – SubjectFull: Research methodology
        Type: general
      – SubjectFull: Drug resistance
        Type: general
      – SubjectFull: Evaluation research
        Type: general
      – SubjectFull: Comparative studies
        Type: general
      – SubjectFull: Randomized controlled trials
        Type: general
      – SubjectFull: Blind experiment
        Type: general
      – SubjectFull: Ambulatory blood pressure monitoring
        Type: general
      – SubjectFull: Angiotensin receptors
        Type: general
      – SubjectFull: Statistical sampling
        Type: general
      – SubjectFull: Innervation
        Type: general
      – SubjectFull: Europe
        Type: general
    Titles:
      – TitleFull: Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Azizi, Michel
      – PersonEntity:
          Name:
            NameFull: Sanghvi, Kintur
      – PersonEntity:
          Name:
            NameFull: Saxena, Manish
      – PersonEntity:
          Name:
            NameFull: Gosse, Philippe
      – PersonEntity:
          Name:
            NameFull: Reilly, John P
      – PersonEntity:
          Name:
            NameFull: Levy, Terry
      – PersonEntity:
          Name:
            NameFull: Rump, Lars C
      – PersonEntity:
          Name:
            NameFull: Persu, Alexandre
      – PersonEntity:
          Name:
            NameFull: Basile, Jan
      – PersonEntity:
          Name:
            NameFull: Bloch, Michael J
      – PersonEntity:
          Name:
            NameFull: Daemen, Joost
      – PersonEntity:
          Name:
            NameFull: Lobo, Melvin D
      – PersonEntity:
          Name:
            NameFull: Mahfoud, Felix
      – PersonEntity:
          Name:
            NameFull: Schmieder, Roland E
      – PersonEntity:
          Name:
            NameFull: Sharp, Andrew S P
      – PersonEntity:
          Name:
            NameFull: Weber, Michael A
      – PersonEntity:
          Name:
            NameFull: Sapoval, Marc
      – PersonEntity:
          Name:
            NameFull: Fong, Pete
      – PersonEntity:
          Name:
            NameFull: Pathak, Atul
      – PersonEntity:
          Name:
            NameFull: Lantelme, Pierre
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 06
              Text: 6/26/2021
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 01406736
          Numbering:
            – Type: volume
              Value: 397
            – Type: issue
              Value: 10293
          Titles:
            – TitleFull: Lancet
              Type: main
ResultId 1